腹腔镜机器人手术在结直肠癌中的研究进展与临床思考
Research Advances and Clinical Perspectives on Laparoscopic and Robot-Assisted Surgery for Colorectal Cancer
投稿时间:2026-11-03  修订日期:2026-11-03
DOI:
中文关键词:  结直肠肿瘤  腹腔镜  机器人辅助手术  循证医学  器官保留
英文关键词:colorectal cancer  laparoscopy  robotic surgical procedures  evidence-based medicine  organ preservation
基金项目:浙江省“尖兵”“领雁”科技计划项目(2026C02A1094);国家中医药管理局科技司-浙江省共建项目(GZY-ZJ-KJ-24005);国家科技四大慢病重大专项(2025ZD0544900)
作者单位邮编
王洋 浙江省肿瘤医院,中国科学院杭州医学研究所 310022
马德宁  
王猛  
王红艳  
计洋  
潘财旭  
朱玉萍* 浙江省肿瘤医院,中国科学院杭州医学研究所 310005
摘要点击次数: 13
全文下载次数: 5
中文摘要:
      腹腔镜手术已广泛用于结直肠癌根治性切除,随机对照试验及长期随访支持其肿瘤学安全性,并为低位直肠癌的保肛治疗提供了依据。机器人辅助腹腔镜手术在部分中低位直肠癌患者中显示出切除质量、局部控制和功能恢复方面的优势,但其在结肠癌中的额外获益、总生存优势及成本效益仍需明确。分子分型、新辅助治疗和观察等待策略的发展,使外科决策不仅涉及手术方式,也涉及是否需要切除直肠。本文结合主要指南与关键临床研究,分析现有证据的临床意义及适用范围,区分保肛切除与非手术器官保留,讨论国产机器人评价、质量控制及未来研究方向,为个体化治疗提供参考。
英文摘要:
      Laparoscopic surgery is widely used for curative colorectal cancer resection. Randomized trials and long-term follow-up support its oncological safety and its role in sphincter-preserving surgery for low rectal cancer. Robot-assisted laparoscopy has shown advantages in resection quality, local control, and functional recovery in selected patients with middle or low rectal cancer, but its additional benefits in colon cancer, overall survival, and cost-effectiveness remain uncertain. Molecular profiling, neoadjuvant treatment, and watch-and-wait strategies now influence not only the surgical approach but also whether rectal resection is needed. Drawing on major guidelines and pivotal clinical studies, this commentary examines the clinical implications and applicability of the evidence, distinguishes sphincter-preserving resection from nonoperative organ preservation, and discusses the evaluation of robotic systems developed in China, quality assurance, and future research priorities.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器